{"id":"https://openalex.org/W2589986757","doi":"https://doi.org/10.1002/nau.23189","title":"Indirect treatment comparison (ITC) of medical therapies for an overactive bladder","display_name":"Indirect treatment comparison (ITC) of medical therapies for an overactive bladder","alternate_titles":[],"publication_year":2017,"publication_date":"2017-02-21","ids":{"openalex":"https://openalex.org/W2589986757","doi":"https://doi.org/10.1002/nau.23189","mag":"2589986757","pmid":"https://pubmed.ncbi.nlm.nih.gov/28220521"},"language":"en","primary_location":{"id":"doi:10.1002/nau.23189","doi":"https://doi.org/10.1002/nau.23189","is_oa":false,"landing_page_url":"https://doi.org/10.1002/nau.23189","pdf_url":null,"source":{"id":"https://openalex.org/S22797964","display_name":"Neurourology and Urodynamics","issn_l":"0733-2467","issn":["0733-2467","1520-6777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurourology and Urodynamics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2589986757"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009936863","display_name":"Aneta Obloza","orcid":"https://orcid.org/0000-0003-3086-0733","observed_orcids":["https://orcid.org/0000-0003-3086-0733"]},"institutions":[{"id":"https://openalex.org/I2800440371","display_name":"Leicester General Hospital","ror":"https://ror.org/02zg49d29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800440371","https://openalex.org/I2802445252"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Aneta Obloza","raw_affiliation_strings":["Department of Urogynaecology, Leicester General Hospital, Leicester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urogynaecology, Leicester General Hospital, Leicester, UK","institution_ids":["https://openalex.org/I2800440371"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joshua Kirby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joshua Kirby","raw_affiliation_strings":["Medical School, University of Birmingham, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Derrick Yates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099987","display_name":"Birmingham Women's Hospital","ror":"https://ror.org/00xe5zs60","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210099987","https://openalex.org/I4210155225"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Derrick Yates","raw_affiliation_strings":["Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I4210099987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069639313","display_name":"Philip M. Toozs-Hobson","orcid":"https://orcid.org/0000-0002-1859-9934","observed_orcids":["https://orcid.org/0000-0002-1859-9934"]},"institutions":[{"id":"https://openalex.org/I4210099987","display_name":"Birmingham Women's Hospital","ror":"https://ror.org/00xe5zs60","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210099987","https://openalex.org/I4210155225"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philip Toozs-Hobson","raw_affiliation_strings":["Department of Urogynaecology, Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urogynaecology, Birmingham Women's Hospital NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I4210099987"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5009936863"],"corresponding_institution_ids":["https://openalex.org/I2800440371"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":null,"fwci":2.039,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.8519649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"36","issue":"7","first_page":"1824","last_page":"1831"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10418","display_name":"Pelvic floor disorders treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.9160000085830688},{"id":"https://openalex.org/keywords/indirect-treatment-comparison","display_name":"indirect treatment comparison","score":0.8510000109672546},{"id":"https://openalex.org/keywords/mirabegron","display_name":"mirabegron","score":0.9660000205039978},{"id":"https://openalex.org/keywords/anticholinergic-drugs","display_name":"anticholinergic agents","score":0.9760000109672546},{"id":"https://openalex.org/keywords/solifenacin","display_name":"solifenacin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/urinary-incontinence","display_name":"urinary incontinence","score":0.7699999809265137},{"id":"https://openalex.org/keywords/urgency","display_name":"urgency","score":0.5109999775886536},{"id":"https://openalex.org/keywords/micturition","display_name":"micturition","score":0.8640000224113464},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/treatment-effectiveness","display_name":"treatment effectiveness","score":0.4830000102519989},{"id":"https://openalex.org/keywords/bucher-method","display_name":"Bucher method","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C2778164427","wikidata":"https://www.wikidata.org/wiki/Q3702534","display_name":"Mirabegron","level":4,"score":0.9323443174362183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8951689600944519},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.8884630799293518},{"id":"https://openalex.org/C2779502394","wikidata":"https://www.wikidata.org/wiki/Q59575279","display_name":"Solifenacin","level":4,"score":0.818464457988739},{"id":"https://openalex.org/C175768497","wikidata":"https://www.wikidata.org/wiki/Q105726","display_name":"Urination","level":3,"score":0.62595534324646},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5829476118087769},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.498687744140625},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43159353733062744},{"id":"https://openalex.org/C2778531004","wikidata":"https://www.wikidata.org/wiki/Q281490","display_name":"Urinary incontinence","level":2,"score":0.4226210117340088},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3838499188423157},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.35425153374671936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30321836471557617},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.17660346627235413},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.1381622552871704},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000083","descriptor_name":"Acetanilides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014554","descriptor_name":"Urination","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018680","descriptor_name":"Cholinergic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018680","descriptor_name":"Cholinergic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064804","descriptor_name":"Urological Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D064804","descriptor_name":"Urological Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/nau.23189","doi":"https://doi.org/10.1002/nau.23189","is_oa":false,"landing_page_url":"https://doi.org/10.1002/nau.23189","pdf_url":null,"source":{"id":"https://openalex.org/S22797964","display_name":"Neurourology and Urodynamics","issn_l":"0733-2467","issn":["0733-2467","1520-6777"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurourology and Urodynamics","raw_type":"journal-article"},{"id":"pmid:28220521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28220521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurourology and urodynamics","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320276","display_name":"University of Leicester","ror":"https://ror.org/04h699437"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1489359480","https://openalex.org/W1575778540","https://openalex.org/W1605716039","https://openalex.org/W1720940903","https://openalex.org/W1966793573","https://openalex.org/W1967312126","https://openalex.org/W1989155778","https://openalex.org/W1994653403","https://openalex.org/W1999745497","https://openalex.org/W1999811720","https://openalex.org/W2001275235","https://openalex.org/W2005256857","https://openalex.org/W2005405390","https://openalex.org/W2005947177","https://openalex.org/W2013908993","https://openalex.org/W2021257414","https://openalex.org/W2025864351","https://openalex.org/W2035613798","https://openalex.org/W2037171825","https://openalex.org/W2037706235","https://openalex.org/W2043938107","https://openalex.org/W2054263301","https://openalex.org/W2062747862","https://openalex.org/W2064365016","https://openalex.org/W2067945145","https://openalex.org/W2070917231","https://openalex.org/W2075335601","https://openalex.org/W2082897746","https://openalex.org/W2084315237","https://openalex.org/W2091025952","https://openalex.org/W2107806473","https://openalex.org/W2110991424","https://openalex.org/W2120598941","https://openalex.org/W2120771911","https://openalex.org/W2131173377","https://openalex.org/W2134928141","https://openalex.org/W2135162196","https://openalex.org/W2137090901","https://openalex.org/W2156871467","https://openalex.org/W4245187582"],"related_works":["https://openalex.org/W2615637025","https://openalex.org/W2084800003","https://openalex.org/W1986758727","https://openalex.org/W2161947438","https://openalex.org/W4402947107","https://openalex.org/W2729515254","https://openalex.org/W2537865294","https://openalex.org/W2595635328","https://openalex.org/W2800933213","https://openalex.org/W4297965543"],"abstract_inverted_index":{"BACKGROUND:":[0],"Overactive":[1],"bladder":[2],"syndrome":[3],"(OAB)":[4],"is":[5,175,217],"a":[6,13,41,53,213],"chronic":[7],"and":[8,164,227,241],"prevalent":[9],"condition":[10],"which":[11,29,151,187],"has":[12],"negative":[14],"impact":[15],"on":[16,65],"Quality":[17],"of":[18,23,34,50,56,78,103,112,121,147,154,166,182,236],"Life.":[19],"The":[20],"National":[21],"Institute":[22],"Clinical":[24],"Excellence":[25],"issued":[26],"two":[27],"documents":[28],"give":[30],"slightly":[31],"varying":[32],"algorithms":[33],"pharmacotherapy":[35],"for":[36,82,105,185],"OAB,":[37,183],"offering":[38],"mirabegron":[39,148,174],"as":[40,176,178],"possible":[42],"treatment":[43,69,87,170,200,238],"in":[44,68,161,180],"certain":[45],"circumstances.":[46],"In":[47,137],"the":[48,66,113,119,122,232],"absence":[49],"trials":[51,99],"involving":[52],"direct":[54],"comparison":[55,60,88],"therapies,":[57],"an":[58],"indirect":[59,86,110,169],"can":[61],"provide":[62],"useful":[63],"information":[64],"difference":[67],"effects":[70,115],"between":[71],"competing":[72],"interventions.":[73],"OBJECTIVE:":[74],"To":[75],"compare":[76],"effectiveness":[77,102],"available":[79],"medical":[80],"therapies":[81],"OAB":[83,106],"using":[84,127],"Bucher":[85,128],"(ITC)":[89],"model.":[90],"METHODS:":[91],"A":[92],"systematic":[93],"literature":[94],"search":[95],"identified":[96],"randomised":[97],"controlled":[98],"(RCT)":[100],"assessing":[101],"drugs":[104],"versus":[107],"placebo.":[108],"Then":[109],"comparisons":[111],"treatments":[114],"were":[116,145,152],"made,":[117],"preserving":[118],"randomisation":[120],"originally":[123],"assigned":[124],"patient":[125,206,222],"groups,":[126],"method.":[129],"MAIN":[130],"RESULTS:":[131],"25":[132],"RCTs":[133],"met":[134],"inclusion":[135],"criteria.":[136],"keeping":[138],"with":[139,243],"ITC":[140],"method":[141],"validity,":[142],"four":[143],"assessments":[144],"undertaken":[146],"against":[149],"anticholinergics,":[150],"number":[153],"incontinence":[155],"episodes,":[156,158],"micturition":[157],"urgency":[159],"episodes":[160],"24":[162],"h":[163],"volume":[165],"micturition.":[167],"This":[168],"analysis":[171],"suggests":[172],"that":[173,196,229],"effective":[177,234],"anticholinergics":[179],"managing":[181,237],"except":[184],"solifenacin":[186],"appears":[188],"to":[189,205,212,219],"be":[190,203,225],"superior.":[191],"CONCLUSIONS:":[192],"These":[193],"findings":[194],"suggest":[195],"work":[197,216],"looking":[198],"into":[199],"choice":[201],"should":[202],"individualized":[204],"characteristics":[207,223],"rather":[208],"than":[209],"fitting":[210],"patients":[211,240],"treatment.":[214],"Further":[215],"required":[218],"identify":[220],"what":[221],"may":[224],"crucial":[226],"indicate":[228],"studies":[230],"exploring":[231],"most":[233],"sequence":[235],"na\u00efve":[239],"those":[242],"refractory":[244],"disease.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2589986757","counts_by_year":[{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-03-03T00:00:00"}
